NCT04386824

Brief Summary

It was aimed to demonstrate whether erectile dysfunction is affected by BH pathogenesis and whether there is a relationship between erectile dysfunction and BD pathogenesis by assessing both sexual function and retinal micro-vascular blood flow in BH which may involve vessels from all calibrations and nature.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2019

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 2, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 13, 2020

Completed
Last Updated

May 13, 2020

Status Verified

May 1, 2020

Enrollment Period

6 months

First QC Date

May 2, 2020

Last Update Submit

May 12, 2020

Conditions

Keywords

Behçet's diseaseerectile dysfunction

Outcome Measures

Primary Outcomes (2)

  • International Index of Erectile Function-15

    This scale assessing the quality of erectile function within the previous 4 weeks was developed by Rosen et al. in 1997. The Turkish validity study was performed by Turunç et al. \[30\]. The IIEF-15 assesses male sexual function in 5 domains: erectile function (1-30 points), orgasmic function (0-10 points), sexual desire (2-10 points), sexual satisfaction from intercourse (0-15 points) and overall satisfaction (2-10 points). In contrast to other functions, the severity of erectile dysfunction can be rated with an overall score ranging from 6 to 30 points. Erectile function was graded as follows: 0-10 points as severe erectile dysfunction (ED); 11-16 points as moderate ED; 17-21 points as mild-moderate ED; 22-25 points as mild ED; 26-30 points as no erectile dysfunction.

    1 week

  • Optical coherence tomography angiography

    It is a functional method that detects the movement contrast in the bloodstream and displays the capillary nets of the retina and choroid and the outer retina without using paint.It is a non-invasive method that provides static volumetric angiography information.From the quantitative measurement results presented by calculating automatically by the software used by the device, the area of the foveal avascular zone (PHASE), the value of the asymmetric index (AI), the superficial and Vascular density (VD) percentages and retinal thickness values in deep capillary plexuses were included in the study.OCTA findings are classified in stages 1-5. OCTA findings worsen as the stage number increases. While stage 1 shows normal superficial capillary plexus; In stage 5, decreased vascular density in the outer retina and significant thinning in the retina are observed.

    1 week

Study Arms (1)

Behçet's disease

Male patients who arediagnosed as Behçet's disease according to International Study Group Classification Criteria

Other: Erectil dysfunction

Interventions

A complete ophthalmological examination including best-corrected visual acuity using the decimal system (BCVA), measurement of intraocular pressure (IOP) and axial length (AL), slit-lamp examination and dilated fundus examination

Also known as: Ophthalmological Examination
Behçet's disease

Eligibility Criteria

Age18 Years - 65 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsmale with Behçet's patients
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Behçet's disease (BD) is a chronic, multi-systemic vasculitis characterized by remissions and exacerbations, where etiology hasn't been fully elucidated \[1\]. It was first described as oral aphthae, genital ulcerations, and iridocyclitis with hypopyon by Hulusi Behçet in 1937 \[2\]. Although its etiology hasn't been fully understood, it is widely accepted that the disease is caused by excessive inflammatory response triggered by environmental factors in individuals with genetic susceptibility

You may qualify if:

  • Definitive diagnosis of Behçet Disease
  • No comorbid disease known to be associated with erectile dysfunction, including hypertension and diabetes mellitus
  • Not overweight or obese (BMI≤25 kg/m2)
  • Non-smokers
  • No alcohol and/or substance abuse
  • No known psychiatric disorder

You may not qualify if:

  • prostatic disorder
  • medication that may influence on erectile function (antihistamines, ß-blockers, etc.)
  • sacroiliac joint or chronic articular involvement
  • family history of glaucoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antalya Tarining and Research Hospital Ethics Commitee

Antalya, Muratpasa, 07070, Turkey (Türkiye)

Location

Related Publications (1)

  • Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford). 2006 Dec;45(12):1461-5. doi: 10.1093/rheumatology/kel329. Epub 2006 Sep 23. No abstract available.

MeSH Terms

Conditions

Behcet SyndromeErectile Dysfunction

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesUveitis, AnteriorPanuveitisUveitisUveal DiseasesEye DiseasesVasculitisVascular DiseasesCardiovascular DiseasesHereditary Autoinflammatory DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, GeneticSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, VascularGenital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Officials

  • Ayse Ayan, Dr.

    Antalya Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc Prof, Dr

Study Record Dates

First Submitted

May 2, 2020

First Posted

May 13, 2020

Study Start

June 15, 2019

Primary Completion

December 10, 2019

Study Completion

December 15, 2019

Last Updated

May 13, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Plan will be shared with Statistical Package for the Social Sciences version 20.

Locations